Cover Image
市場調查報告書

腎臟病:全球臨床實驗趨勢

Nephropathy Global Clinical Trials Review, H2, 2015

出版商 GlobalData 商品編碼 326149
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
腎臟病:全球臨床實驗趨勢 Nephropathy Global Clinical Trials Review, H2, 2015
出版日期: 2015年09月10日 內容資訊: 英文 76 Pages
簡介

本報告提供腎臟病相關之臨床研究最新趨勢調查,提供您地區·進展·Phase·募集情況別的實驗量,並彙整代表性贊助商,開發中的治療藥資訊,全球各國的主要企業·機關進展,有潛力的藥劑比較等資訊。

簡介

  • 腎臟病
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要國家的臨床實驗數量
    • 中南美主要國家的臨床實驗數量

G7各國臨床實驗數量:泌尿生殖系統系及性荷爾蒙相關臨床實驗上,腎臟病的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:泌尿生殖系統系及性荷爾蒙相關臨床實驗上,腎臟病的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別臨床實驗數量

有潛力的贊助商

腎臟病治療藥臨床實驗的主要參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Pfizer Inc.
    • Novartis AG
    • Mallinckrodt plc
    • Rigel Pharmaceuticals, Inc.
    • Kliniken der Stadt Koln gGmbH
    • AstraZeneca PLC
    • Astellas Pharma Inc.
    • Anthera Pharmaceuticals, Inc.
    • AbbVie Inc.
  • 有代表性的研究機關·醫院臨床實驗概要
    • Mayo Clinic
    • Nanjing Medical University
    • Seoul National University Hospital
    • Guangdong General Hospital
    • Regional Hospital Holstebro
    • Tehran University of Medical Sciences
    • Leiden University Medical Center
    • Sun Yat-sen University
    • Ospedale Misericordia e Dolce
    • Assistance Publique - Hopitaux de Paris

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2854CTIDB

GlobalData's clinical trial report, "Nephropathy Global Clinical Trials Review, H2, 2015" provides an overview of Nephropathy clinical trials scenario. This report provides top line data relating to the clinical trials on Nephropathy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Nephropathy
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Nephropathy
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Nephropathy Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Novartis AG
      • Clinical Trial Overview of Novartis AG
      • F. Hoffmann-La Roche Ltd.
      • Clinical Trial Overview of F. Hoffmann-La Roche Ltd.
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • Mallinckrodt Plc
      • Clinical Trial Overview of Mallinckrodt Plc
      • Rigel Pharmaceuticals, Inc.
      • Clinical Trial Overview of Rigel Pharmaceuticals, Inc.
      • AstraZeneca Plc
      • Clinical Trial Overview of AstraZeneca Plc
      • Cumberland Pharmaceuticals, Inc.
      • Clinical Trial Overview of Cumberland Pharmaceuticals, Inc.
      • Astellas Pharma Inc.
      • Clinical Trial Overview of Astellas Pharma Inc.
      • Anthera Pharmaceuticals, Inc.
      • Clinical Trial Overview of Anthera Pharmaceuticals, Inc.
      • AbbVie Inc.
      • Clinical Trial Overview of AbbVie Inc.
    • Clinical Trial Overview of Top Institutes / Government
      • Mayo Clinic
      • Clinical Trial Overview of Mayo Clinic
      • Leiden University Medical Center
      • Clinical Trial Overview of Leiden University Medical Center
      • Nanjing Medical University
      • Clinical Trial Overview of Nanjing Medical University
      • Ospedale Misericordia e Dolce
      • Clinical Trial Overview of Ospedale Misericordia e Dolce
      • Regional Hospital Holstebro
      • Clinical Trial Overview of Regional Hospital Holstebro
      • Seoul National University Hospital
      • Clinical Trial Overview of Seoul National University Hospital
      • Radboud University
      • Clinical Trial Overview of Radboud University
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • The National Institute of Allergy and Infectious Diseases
      • Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases
      • A. Manzoni Hospital
      • Clinical Trial Overview of A. Manzoni Hospital
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Nephropathy Therapeutics, Global, Clinical Trials by Region, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Nephropathy Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015*
  • Nephropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nephropathy Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Nephropathy Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Nephropathy Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mallinckrodt Plc, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigel Pharmaceuticals, Inc., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Cumberland Pharmaceuticals, Inc., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Astellas Pharma Inc., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Anthera Pharmaceuticals, Inc., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Medical University, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ospedale Misericordia e Dolce, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Regional Hospital Holstebro, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Radboud University, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015*
  • Nephropathy Therapeutics Clinical Trials Market, Global, Clinical Trials by A. Manzoni Hospital, 2015*

List of Figures

  • Nephropathy Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Nephropathy Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Nephropathy Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Nephropathy Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Nephropathy Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015*
  • Nephropathy Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2015*
  • Nephropathy Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Nephropathy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Nephropathy to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2015*
  • Nephropathy Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Nephropathy Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Nephropathy Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Nephropathy Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Nephropathy Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top